Negative WPI Set To Trigger Price Cuts In India?
This article was originally published in Scrip
Executive Summary
The going has generally been tough for pharmaceutical firms in India this past year, stretched by volatility in certain emerging markets and plant woes, but the industry there should probably steel itself for yet more pain on its home turf.